Teva Capitalizes On Patent Expiry To Launch First Perforomist Rival
Analyst Projects Financial Hit For Originator Viatris
Teva has added to its vast portfolio in the US by introducing the first generic version of Viatris’ Perforomist for chronic obstructive pulmonary disease, as well as a generic of Soolantra to treat rosacea.
